Targeted Alpha Therapy (TAT) with Single-Domain Antibodies (Nanobodies)

Kate Hurley, Meiyun Cao, Haiming Huang, Yi Wang

Open source

DOI
10.3390/cancers15133493
Published
2023-07-04
Container
Cancers
Publisher
MDPI AG
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/cancers15133493,
  title = {Targeted Alpha Therapy (TAT) with Single-Domain Antibodies (Nanobodies)},
  author = {Kate Hurley and Meiyun Cao and Haiming Huang and Yi Wang},
  year = {2023},
  journal = {Cancers},
  doi = {10.3390/cancers15133493},
  url = {https://doi.org/10.3390/cancers15133493}
}

RIS

TY  - JOUR
TI  - Targeted Alpha Therapy (TAT) with Single-Domain Antibodies (Nanobodies)
AU  - Kate Hurley
AU  - Meiyun Cao
AU  - Haiming Huang
AU  - Yi Wang
PY  - 2023
JO  - Cancers
DO  - 10.3390/cancers15133493
UR  - https://doi.org/10.3390/cancers15133493
ER  - 

APA

Hurley, K., Cao, M., Huang, H., & Wang, Y. (2023). Targeted Alpha Therapy (TAT) with Single-Domain Antibodies (Nanobodies). Cancers. https://doi.org/10.3390/cancers15133493

Source records